STOCK TITAN

TOMI preliminary Q3 revenue rises 24% to $2.49M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

TOMI Environmental Solutions, Inc. (TOMZ) reported preliminary, unaudited Q3 2026 revenue of $2,492,801, up 24% from $2,011,556 a year earlier. Gross profit increased 19% to $1,469,921, while gross margin was 59.0% versus 61.2%. Operating expenses fell 7% to $1,439,874, and income from operations was $30,047, compared with a $321,415 loss in Q3 2025. Nine-month revenue increased 38% to $6,393,937.

Sales backlog was approximately $2.5 million at September 30, 2026 and approximately $2.8 million subsequently; the sales pipeline was approximately $35 million, with approximately 25% in advanced stages. TOMI reported converting $2.5 million of convertible notes during Q3.

Results remain subject to change: TOMI and its independent registered public accounting firm had not completed their review of the notes’ accounting treatment. The company said the review could affect net loss and liability and shareholders’ equity balances, but was not expected to affect reported revenue, gross profit, operating expenses or income from operations.

4 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

How the balance works

Positive

  • Moderate pointQ3 revenue rose 24% to $2,492,801 year over year.
  • Moderate pointQ3 operating income was $30,047, versus a Q3 2025 operating loss.
  • Moderate pointGross profit increased 19% to $1,469,921 year over year.
  • Minor pointNine-month revenue rose 38% to $6,393,937 year over year.

Negative

  • None.
Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Q3 revenue $2,492,801 Three months ended September 30, 2026; up 24% year over year.
Gross profit $1,469,921 Q3 2026; up 19% year over year.
Income from operations $30,047 Q3 2026, compared with a $321,415 operating loss in Q3 2025.
Operating expenses $1,439,874 Q3 2026; down 7% year over year.
Nine-month revenue $6,393,937 Nine months ended September 30, 2026; up 38% year over year.
Sales backlog Approximately $2.5 million at September 30, 2026; approximately $2.8 million subsequently Reported at quarter-end and subsequently.
Convertible notes converted $2.5 million Conversion reported during Q3 2026.
Sales pipeline Approximately $35 million; approximately 25% in advanced stages Company sales pipeline reported for Q3 2026.
Binary Ionization Technology® technical
"premier Binary Ionization Technology® (BIT™) platform"
ionized Hydrogen Peroxide (iHP™) technical
"fog of ionized Hydrogen Peroxide (iHP™)"
gross margin financial
"Gross margin was 59.0%"
Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.
convertible notes financial
"accounting treatment for the Company’s convertible notes"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
sales backlog financial
"Sales backlog totaled approximately $2.5 million"
sales pipeline financial
"total sales pipeline was approximately $35 million"
A sales pipeline is a staged view of potential customers at each step from first contact to a completed sale, showing how many prospects are in play and how far they’ve progressed. Investors watch it like a factory conveyor belt: a healthy, steadily moving pipeline signals likely future revenue and growth, while gaps or bottlenecks can warn that sales targets and cash flow may be at risk.
Q3 revenue $2,492,801 Up 24% year over year and 11% sequentially
Gross profit $1,469,921 Up 19% year over year
Gross margin 59.0% Compared with 61.2% in Q3 2025
Income from operations $30,047 Compared with a $321,415 operating loss in Q3 2025
Operating expenses $1,439,874 Down 7% year over year
Nine-month revenue $6,393,937 Up 38% year over year
Guidance

The company expected shareholders’ equity at September 30, 2026 to be in the range of $3 million to $4 million.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were TOMZ’s Q3 2026 revenue and operating income?

TOMZ reported preliminary, unaudited revenue of $2,492,801 and income from operations of $30,047 for the three months ended September 30, 2026. Revenue was up 24% from $2,011,556, and income from operations compared with a $321,415 operating loss in Q3 2025.

How much were TOMZ’s sales backlog and pipeline?

At September 30, 2026, TOMZ’s sales backlog was approximately $2.5 million and subsequently increased to approximately $2.8 million. Its sales pipeline was approximately $35 million, with approximately 25% in advanced stages.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
 
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 12, 2026

 

TOMI ENVIRONMENTAL SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

Florida

 

000-09908

 

59-1947988

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

8430 Spires Way

Frederick, Maryland21701

(Address of principal executive offices) (Zip Code)

 

(800) 525-1698

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value per share

TOMZ

Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

 

 

 

 

 

Item 2.02Results of Operations and Financial Condition.

 

On November 12, 2026, TOMI Environmental Solutions, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2026. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1. No additional information is included in this Current Report on Form 8-K.

 

The information included in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed “filed” for purposes of, nor shall it be deemed incorporated by reference in, any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

See the Exhibit Index below, which is incorporated by reference herein.

 

Exhibit No.

 

Description

99.1

 

Press Release date November 12, 2026

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

2

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TOMI ENVIRONMENTAL SOLUTIONS, INC.

 

 

 

 

 

Date: November 13, 2026

By:

/s/ Halden S. Shane

 

 

 

Name: Halden S. Shane

 

 

 

Title: Chief Executive Officer

 

 

 

3

 

EXHIBIT 99.1

 

TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Financial Results

Company Delivers 24% Q3 Revenue Growth and Returns to Positive Operating Income


FREDERICK, Md., Nov. 12, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today announced preliminary financial results for the three and nine months ended September 30, 2026, and provided an update on strategic initiatives.

 

Select financial and operational achievements for the quarter are as follows:

 

●  Q3 Revenue Increased 24% Year-Over-Year to $2.49 Million; Sequential Revenue Increased 11% Over Q2 2026.

 

●  Achieved Positive Operating Income: Generated approximately $30,000 of operating income, representing the Company’s first positive quarterly operating result since the third quarter of 2024.

 

●  Gross Profit Increased 19% to $1.47 Million; Gross Margin was 59.0%.

 

●  Operating Expenses Decreased 7% Year-Over-Year and 12% Sequentially, reflecting continued expense discipline.

 

●  Sales Backlog Reached Approximately $2.5 Million at Quarter-End and Approximately $2.8 Million Subsequently, supporting near-term revenue visibility.

 

●  The company expects shareholders’ equity at September 30, 2026 to be in the range of $3 Million to $4 Million

 

The financial results in this press release are preliminary and unaudited. The Company and its independent registered public accounting firm have not yet completed their review of the accounting treatment for the Company’s convertible notes, including the conversion of $2.5 million of notes during the third quarter. Accordingly, this release does not include financial results that may be affected by that review, including any gain or loss associated with the conversion, net loss, net loss per share, and the related liability and stockholders’ equity balances. Based on information currently available, the Company does not expect the review to affect the revenue, gross profit, operating expense or income from operations figures presented in this release; however, all results remain subject to change until the Company files its Quarterly Report on Form 10-Q for the period ended September 30, 2026.

 

Executive Commentary

 

Dr. Halden Shane, CEO of TOMI Environmental Solutions, commented, “The third quarter represented an important inflection point for TOMI. Revenue increased 24% year-over-year and 11% sequentially, and we returned to positive operating income for the first time since the third quarter of 2024. This progress reflects stronger commercial execution, improved equipment sales and disciplined management of our operating cost base.”

 

“We also materially improved our capital structure during the quarter. The conversion of $2.5 million of convertible notes significantly reduced our debt obligations and expected annual cash interest commitment. Combined with an expanding backlog and commercial pipeline, we believe these improvements provide a stronger foundation as we work toward sustained profitability.”

 

“Operationally, momentum continued across mobile equipment, SteraMist applicators, BIT Solution consumables and support services. We also advanced our food safety, life sciences, defense and international regulatory initiatives, including the expanded AgriMist registration and independent Listeria biofilm data. We remain focused on converting our backlog and pipeline, increasing recurring revenue and delivering sustainable growth.”

 

 

1

 

 

 

Q3 2026 Highlights:

 

●  Revenue Growth: Q3 2026 revenue was $2,492,801, a 24% increase from $2,011,556 in Q3 2025 and an 11% sequential increase from $2,246,909 in Q2 2026. Nine-month revenue increased 38% to $6,393,937 from $4,619,229.

 

●  Positive Operating Income: Income from operations was $30,047, compared with an operating loss of ($321,415) in Q3 2025 and an operating loss of ($244,142) in Q2 2026.

 

●  Gross Profit Growth: Gross profit increased 19% to $1,469,921 from $1,231,971 in Q3 2025. Gross margin was 59.0%, compared with 61.2% in the prior-year quarter.

 

●  Disciplined Operating Expenses: Operating expenses decreased 7% year-over-year to $1,439,874 from $1,553,386 and decreased 12% sequentially from $1,629,448 in Q2 2026.

 

●  Product and Domestic Revenue Growth: Product revenue increased 30% to approximately $2.08 million, while U.S. revenue increased 50% to approximately $1.92 million.

 

●  Strong Product and Service Order Growth: Based on 2026 invoiced sales and open orders, iHP Support Services increased approximately 133%, Mobile Equipment increased approximately 106%, and CES/Enclosure sales increased approximately 259% compared with full-year 2025 levels. BIT Solution sales are on track to exceed 2025.

 

●  Expanded Backlog and Pipeline: Sales backlog totaled approximately $2.5 million at September 30, 2026 and subsequently increased to approximately $2.8 million. The Company’s total sales pipeline was approximately $35 million, with approximately 25% in advanced stages.

 

Financial Results for the Three and Nine Months Ended September 30, 2026, Compared to September 30, 2025

 

●  Nine-month performance: Revenue increased 38%, gross profit increased 29%, operating expenses declined 11%, and operating loss improved approximately 62%.

 

●  Sales, net were $2,492,801 for Q3 2026 compared with $2,011,556 for Q3 2025, an increase of $481,245, or 24%. For the nine-month period, sales increased 38% to $6,393,937 from $4,619,229.

 

●  Product revenue increased 30% to approximately $2,078,000 for Q3 2026 from $1,603,000. Service revenue increased 1% to approximately $415,000 from $409,000.

 

●  Geographic performance: U.S. revenue increased 50% to approximately $1,921,000, while international revenue decreased 22% to approximately $572,000.

 

●  Gross profit was $1,469,921, or 59.0% of net sales, compared with $1,231,971, or 61.2% of net sales, for Q3 2025.

 

●  Total operating expenses were $1,439,874, a decrease of $113,512, or 7%, compared with $1,553,386 in Q3 2025.

 

●  Income from operations was $30,047, an improvement of $351,462 compared with a loss from operations of ($321,415) in Q3 2025.

 

Recent Business Highlights:

 

●  On July 20, 2026, the Company effected a 1-for-3 reverse stock split of its Common Stock and Series A Preferred Stock.

 

●  On August 3, 2026, the U.S. Environmental Protection Agency granted a new unconditional registration for SteraMist® (BIT®) – AgriMist (EPA Reg. No. 90150-4), expanding labeled use sites across post-harvest food safety, cannabis and hemp cultivation, and greenhouse and hydroponic agriculture.

 

●  On August 17, 2026, TOMI’s Binary Ionization Technology received formal approval in Ireland under the European Union’s Biocidal Products Regulation, bringing approvals to 11 European markets.

 

●  On September 17, 2026, TOMI reported approximately $2.3 million in SteraMist iHP enclosure purchase orders year-to-date, exceeding approximately $1.6 million in comparable enclosure orders over the prior four years combined.

 

●  On September 18, 2026, TOMI reported year-to-date SteraMist iHP service and support sales of approximately $1.7 million, exceeding the approximately $1.3 million recorded in each of full-year 2024 and full-year 2025.

 

●  On September 21, 2026, TOMI announced the mutual termination of its definitive merger agreement with Carbonium Core, Inc. Each party will bear its own fees and expenses, and no termination fee was payable.

 

●  On September 29, 2026, TOMI announced modular integration concepts for its SteraMist iHP platform targeting autonomous vehicle fleets, drone platforms and robotic systems.

 

●  On September 30, 2026, TOMI announced that Project MEND implemented SteraMist iHP to disinfect reusable durable medical equipment before redistribution.

 

 

2

 

 

 

Post-Quarter Developments:

 

●  TOMI expanded SteraMist iHP into India’s pharmaceutical market through its distribution partner, STS Technocrat (India) Pvt. Ltd., which signed a pharmaceutical customer and is working with TOMI on a turnkey, fully integrated iHP enclosure.

 

●  Independent laboratory results showed SteraMist iHP reduced Listeria monocytogenes biofilm on flat surfaces by an average of more than 7 log and by more than 3 log on hard-to-reach equipment parts.

 

●  On October 11, 2026, the Board appointed Niroshan Srirathan as permanent Chief Financial Officer.

 

Looking Ahead

 

TOMI enters the fourth quarter of 2026 with improved operating performance, a strengthened capital structure and growing commercial visibility. The Company is executing a focused strategy to:

 

●  Convert Commercial Pipeline and Backlog: Deliver on the Company’s approximately $2.8 million post-quarter backlog and convert opportunities within its approximately $35 million sales pipeline.

 

●  Drive Recurring Revenue: Expand BIT Solution consumable sales, applicator adoption and iHP service and support revenue across life sciences, healthcare, food safety and commercial markets.

 

●  Advance Food Safety and Regulatory Pathways: Build on the expanded AgriMist EPA registration, independent Listeria biofilm data and ongoing work toward applicable food-contact and international regulatory authorizations.

 

●  Expand International, Defense and Institutional Sales: Leverage the Company’s regulatory approvals, distributor network and defense-sector relationships to broaden adoption of SteraMist iHP technology.

 

●  Maintain Cost and Capital Discipline: Continue managing operating expenses, liquidity and financing resources while pursuing sustainable profitability.

 

Conference Call Information

 

TOMI will hold a conference call to discuss third quarter 2026 results at 4:30 p.m. ET today, November 12, 2026.

 

To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled start time and provide participant access code 271346 or request the “TOMI Environmental Solutions third quarter earnings call.” International callers should dial (973) 528-0011. To access the live webcast or view the press release, please visit the Investor Relations section of the TOMI website or register at the following link:

 

https://www.webcaster5.com/Webcast/Page/2262/54772

 

A replay of the teleconference will be available until November 19, 2026, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use replay access code 54772. A replay of the webcast will also be available on the company’s website following the completion of the call.

 

 

3

 

 

 

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

 

TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

 

TOMI products are designed to service a broad spectrum of commercial structures, including hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

 

For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends and anticipated business and market conditions. These forward-looking statements include, without limitation, statements regarding TOMI’s expectations concerning future revenue growth, profitability, backlog and pipeline conversion, business development initiatives, recurring revenue, international expansion, regulatory pathways, capital availability, liquidity, operating performance and financial results, including statements under “Looking Ahead.”

 

Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such statements. These risks include, but are not limited to, TOMI’s ability to acquire new customers, expand sales, maintain growth, convert backlog and pipeline opportunities into revenue, improve operating performance, obtain necessary financing, maintain compliance with Nasdaq listing standards, manage customer and supplier concentration, obtain regulatory approvals and successfully commercialize its technologies, as well as changes in market demand, competitive conditions, regulatory developments and economic conditions. Additional risks are described in TOMI’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

 

The information provided in this press release is based on facts and circumstances known at the time of issuance. Actual results may differ materially from those anticipated due to the factors described above and other unknown or unpredictable factors. Readers are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements speak only as of the date of this press release, and TOMI undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.

 

INVESTOR RELATIONS CONTACT:  

John Nesbett/Zach Nevas

IMS Investor Relations  

tomi@imsinvestorrelations.com

 

 

4

 

 

 

TOMI ENVIRONMENTAL SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

 

 

 

 

 

 

As of September 30,

 

 

As of December 31,

 

 

 

2026

 

 

2025

 

 

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

195,162

 

 

$

87,775

 

Accounts receivable, net

 

 

2,592,871

 

 

 

689,153

 

Inventories, net

 

 

2,381,336

 

 

 

2,926,427

 

Vendor deposits

 

 

235,211

 

 

 

161,597

 

Prepaid expenses

 

 

372,229

 

 

 

322,114

 

Other current assets

 

 

143,788

 

 

 

-

 

Total current assets

 

 

5,920,597

 

 

 

4,187,066

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

549,600

 

 

 

614,311

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

Intangible assets, net

 

 

1,341,043

 

 

 

1,351,164

 

Operating lease – right of use asset

 

 

258,059

 

 

 

322,089

 

Other assets

 

 

760,725

 

 

 

559,671

 

Total other assets

 

 

2,359,827

 

 

 

2,232,924

 

Total assets

 

$

8,830,024

 

 

$

7,034,301

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

2,583,459

 

 

$

1,480,189

 

Accrued expenses and other current liabilities

 

 

1,062,441

 

 

 

860,703

 

Deferred revenue

 

 

171,345

 

 

 

424,032

 

Sale of future receipts, net of discount of $0 and $113,191 at September 30, 2026 and December 31, 2025, respectively

 

 

-

 

 

 

254,234

 

Current portion of long-term operating lease

 

 

155,417

 

 

 

143,672

 

Total current liabilities

 

 

3,972,662

 

 

 

3,162,830

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

Long-term operating lease, net of current portion

 

 

252,364

 

 

 

370,591

 

Convertible notes payable, net of unamortized discount of $42,525 and $222,624 at September 30, 2026 and December 31, 2025, respectively

 

 

592,475

 

 

 

2,912,376

 

Total long-term liabilities

 

 

844,839

 

 

 

3,282,967

 

Total liabilities

 

 

4,817,501

 

 

 

6,445,797

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

Cumulative convertible Series A preferred stock; par value $0.01 per share, 1,000,000 shares authorized; 21,250 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively (retroactively adjusted for the 1-for-3 reverse stock split)

 

$

213

 

 

$

213

 

Cumulative convertible Series B preferred stock; $1,000 stated value; 7.5% cumulative dividend; 4,000 shares authorized; none issued and outstanding at September 30, 2026 and December 31, 2025, respectively

 

 

-

 

 

 

-

 

Common stock; par value $0.01 per share, 250,000,000 shares authorized; 10,022,232 and 6,759,157 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively (retroactively adjusted for the 1-for-3 reverse stock split)

 

 

100,222

 

 

 

67,591

 

Additional paid-in capital

 

 

63,346,006

 

 

 

58,572,686

 

Accumulated deficit

 

 

(59,433,917

)

 

 

(58,051,986

)

Total shareholders’ equity

 

 

4,012,524

 

 

 

588,504

 

Total liabilities and shareholders' equity

 

$

8,830,024

 

 

$

7,034,301

 

 

 

5

 

 

 

TOMI ENVIRONMENTAL SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended

 

 

For the nine months ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales, net

 

$

2,492,801

 

 

$

2,011,556

 

 

$

6,393,937

 

 

$

4,619,229

 

Cost of sales

 

 

1,022,880

 

 

 

779,585

 

 

 

2,706,934

 

 

 

1,758,389

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

1,469,921

 

 

 

1,231,971

 

 

 

3,687,003

 

 

 

2,860,840

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Professional fees

 

$

276,021

 

 

$

185,476

 

 

$

800,684

 

 

$

588,666

 

Depreciation and amortization

 

 

47,872

 

 

 

68,588

 

 

 

150,821

 

 

 

206,368

 

Selling expenses

 

 

197,049

 

 

 

143,599

 

 

 

617,377

 

 

 

630,467

 

Research and development

 

 

42,504

 

 

 

10,694

 

 

 

137,376

 

 

 

139,380

 

Consulting fees

 

 

94,692

 

 

 

72,623

 

 

 

341,487

 

 

 

214,792

 

General and administrative

 

 

781,736

 

 

 

1,072,406

 

 

 

2,479,619

 

 

 

3,289,736

 

Total operating expenses

 

 

1,439,874

 

 

 

1,553,386

 

 

 

4,527,364

 

 

 

5,069,409

 

Income (Loss) from operations

 

 

30,047

 

 

 

(321,415

)

 

 

(840,361

)

 

 

(2,208,569

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (Employee Retention Credit)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

534,912

 

Interest income

 

 

2,133

 

 

 

1,406

 

 

 

2,649

 

 

 

85,717

 

Interest expense

 

 

(74,412

)

 

 

(130,339

)

 

 

(397,465

)

 

 

(355,517

)

Loss on extinguishment of convertible debt

 

 

(146,754

)

 

 

-

 

 

 

(146,754

)

 

 

-

 

Total other income (expense)

 

 

(219,033

)

 

 

(128,933

)

 

 

(541,570

)

 

 

265,112

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

(188,986

)

 

 

(450,348

)

 

 

(1,381,931

)

 

 

(1,943,457

)

Provision for income taxes

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

($188,986)

 

 

($450,348)

 

 

($1,381,931)

 

 

($1,943,457)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

($0.02)

 

 

($0.07)

 

 

($0.18)

 

 

($0.29)

 

Diluted

 

($0.02)

 

 

($0.07)

 

 

($0.18)

 

 

($0.29)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

 

8,890,770

 

 

 

6,691,735

 

 

 

7,772,573

 

 

 

6,682,065

 

Diluted weighted average common shares outstanding

 

 

8,890,770

 

 

 

6,691,735

 

 

 

7,772,573

 

 

 

6,682,065

 

 

 

6

 

Filing Exhibits & Attachments

6 documents

Keep reading